1. Home
  2. ACXP vs SLGL Comparison

ACXP vs SLGL Comparison

Compare ACXP & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • SLGL
  • Stock Information
  • Founded
  • ACXP 2017
  • SLGL 1997
  • Country
  • ACXP United States
  • SLGL Israel
  • Employees
  • ACXP N/A
  • SLGL N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • SLGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACXP Health Care
  • SLGL Health Care
  • Exchange
  • ACXP Nasdaq
  • SLGL Nasdaq
  • Market Cap
  • ACXP 31.4M
  • SLGL 30.9M
  • IPO Year
  • ACXP 2021
  • SLGL 2018
  • Fundamental
  • Price
  • ACXP $0.74
  • SLGL $0.61
  • Analyst Decision
  • ACXP Strong Buy
  • SLGL Strong Buy
  • Analyst Count
  • ACXP 1
  • SLGL 2
  • Target Price
  • ACXP $12.00
  • SLGL $5.00
  • AVG Volume (30 Days)
  • ACXP 153.6K
  • SLGL 107.1K
  • Earning Date
  • ACXP 03-14-2025
  • SLGL 03-12-2025
  • Dividend Yield
  • ACXP N/A
  • SLGL N/A
  • EPS Growth
  • ACXP N/A
  • SLGL N/A
  • EPS
  • ACXP N/A
  • SLGL N/A
  • Revenue
  • ACXP N/A
  • SLGL $11,707,000.00
  • Revenue This Year
  • ACXP N/A
  • SLGL $772.97
  • Revenue Next Year
  • ACXP N/A
  • SLGL N/A
  • P/E Ratio
  • ACXP N/A
  • SLGL N/A
  • Revenue Growth
  • ACXP N/A
  • SLGL 869.93
  • 52 Week Low
  • ACXP $0.68
  • SLGL $0.33
  • 52 Week High
  • ACXP $3.35
  • SLGL $1.65
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 43.00
  • SLGL 39.08
  • Support Level
  • ACXP $0.73
  • SLGL $0.55
  • Resistance Level
  • ACXP $0.82
  • SLGL $0.78
  • Average True Range (ATR)
  • ACXP 0.05
  • SLGL 0.09
  • MACD
  • ACXP 0.01
  • SLGL -0.02
  • Stochastic Oscillator
  • ACXP 26.03
  • SLGL 17.14

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.

Share on Social Networks: